ASCEND BY NTHRYS
Research Abroad Products

Applied Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 200 project topics
CAR-T Cell Engineering Platform for Rapid Therapeutic Development
A cloud-based design and optimization platform that streamlines CAR-T cell construct engineering, allowing researchers to model, iterate, and validate therapeutic variants in silico before manufacturing. This accelerates time-to-clinic and reduces development costs, enabling faster commercialization of personalized cancer immunotherapies.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Checkpoint Inhibitor Biomarker Discovery SaaS Suite
A software-as-a-service platform that integrates multi-omics data to predict patient response to PD-1/PD-L1 and CTLA-4 therapies before treatment initiation. This enables pharmaceutical companies to develop companion diagnostics and optimize patient stratification, increasing therapeutic efficacy claims and market exclusivity.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
High-Throughput Neoantigen Identification and Manufacturing Pipeline
An integrated service platform combining genomic sequencing, AI prediction algorithms, and personalized vaccine manufacturing for tumor-specific neoantigens. This delivers a scalable, automated workflow that reduces neoantigen-to-patient turnaround from months to weeks, opening revenue streams in personalized cancer immunotherapy.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Tumor Microenvironment Cellular Profiling and Predictive Analytics Tool
A proprietary software tool leveraging spatial transcriptomics and immunophenotyping data to map immune infiltration, exhaustion, and activation states within solid tumors. This provides pharma clients actionable insights for rational combination therapy design and biomarker-driven clinical trial enrollment strategies.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Immunogenicity Assessment Platform for Therapeutic Protein Drugs
A comprehensive in vitro and in silico platform predicting anti-drug antibody development and T-cell reactivity against biopharmaceuticals before clinical trials. This reduces immunogenicity risk, shortens regulatory timelines, and protects market exclusivity by enabling proactive formulation and manufacturing improvements.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Oncoimmunology Clinical Trial Simulation and Patient Matching Engine
An AI-powered platform that simulates immunotherapy efficacy outcomes and matches patients to optimal trial cohorts based on immune signatures and tumor biology. This reduces trial failure rates, accelerates patient enrollment, and increases probability of regulatory approval for sponsor pharmaceutical companies.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Adoptive T-Cell Manufacturing Quality Control Automation System
An end-to-end automated platform integrating bioreactor monitoring, flow cytometry analytics, and release testing for ex vivo T-cell therapies at GMP scale. This ensures consistent product quality, reduces manufacturing costs per unit, and enables higher margins for clinical-stage cell therapy companies.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Immune Checkpoint Combination Synergy Prediction and Screening Service
A high-throughput screening service platform that identifies synergistic checkpoint inhibitor combinations using patient-derived tumor organoids and ex vivo immune co-cultures. This de-risks combination therapy development and creates clear intellectual property differentiation, enabling clients to command premium pricing in competitive markets.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Therapeutic Cancer Vaccine Design Optimization Platform and Services
A cloud platform combining immunoinformatics, epitope mapping, and immunogenicity modeling to rationally design personalized and off-the-shelf cancer vaccines. This shortens vaccine development cycles and enables rapid commercialization of curative combination regimens with checkpoint inhibitors.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Immune Exhaustion Reversal Drug Screening and Biomarker Platform
A proprietary screening platform using patient-derived tumor-infiltrating lymphocytes to identify and validate small-molecule and biologic agents reversing T-cell exhaustion. This accelerates discovery of next-generation immunotherapies and creates validated biomarkers for patient selection, generating significant downstream licensing and royalty revenue.
Tumor Immunology Drug Discovery Service Platforms Click to view more details →
Automated CAR-T Cell Manufacturing Platform for GMP Compliance
A closed-loop bioreactor system with real-time monitoring and automated control modules that scales CAR-T cell production from research to clinical manufacturing while maintaining FDA/EMA GMP standards. This platform reduces manufacturing costs by 40-60% and accelerates time-to-clinic by 3-6 months, enabling contract manufacturers and biotech firms to establish profitable cell therapy production lines.
Immune Cell Therapy Development & Manufacturing Click to view more details →
AI-Powered Immune Cell Quality Control Analytics Suite
A cloud-based SaaS platform integrating machine learning algorithms to predict cell viability, potency, and safety metrics from real-time flow cytometry and genomic data during manufacturing. This delivers 99.2% accuracy in batch release decisions, reduces quality control timelines from days to hours, and prevents costly manufacturing failures worth millions in lost product.
Immune Cell Therapy Development & Manufacturing Click to view more details →